Curosurf 240mg injection contains active components such as Poractant alfa. It is a lung surfactant medication used to treat Respiratory Distress Syndrome (RDS) in premature infants. It is a lifesaving medication that has improved the survival and outcomes of many premature infants. It has been shown to reduce the risk of death, the need for mechanical ventilation, and the length of hospital stay in premature infants with RDS. It is a good option for infants who are at risk for developing bronchopulmonary dysplasia (BPD), a chronic lung disease that can develop in premature infants. It is more stable than other surfactant medications, which means it can be stored longer without losing effectiveness.

If someone is hypersensitive to Curosurf 240mg injection, they should not receive the medication. They may experience a severe allergic reaction, such as anaphylaxis. It should not be used for infants with severe RDS. This is because the medication may not be effective in these infants. This medication should not be given to infants with a history of porcine protein hypersensitivity. This medication can increase the risk of bleeding. Therefore, it should not be given to infants with active bleeding. It may not be effective in infants with neonatal pneumonia and meconium aspiration syndrome. Curosurf 240mg injection is not used in old age because it is ineffective in adults.

Respiratory distress syndrome (RDS)

Curosurf 240mg injection lowers the surface tension in the lungs by forming a film on the surface of the alveoli, the tiny air sacs in the lungs. This film reduces the force of attraction between the water molecules in the alveoli, making it easier for them to stay open.

Curosurf 240mg injection is administered through a breathing tube into the infant's lungs. This is called endotracheo-pulmonary administration. It is a relatively simple procedure that can be done in a hospital setting.

Anaphylaxis

Bleeding

Pulmonary hemorrhage

Intracranial hemorrhage

Surfactant protein B deficiency

Bradycardia

Hypotension

Hypoxemia (decreased oxygen)

Respiratory distress

Apnea

Froth at the mouth

Irritation at the injection site

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Curosurf 240mg injection, reducing effectiveness by causing undesirable side effects.

Should be stored at room temperature, between 2°C to 8°C

Keep away from moisture, heat, and light.

It should not be frozen.

Keep away from children and pets.

When receiving Curosurf 240mg injection, it is important to tell your doctor about all of your medical conditions and medications. Be aware of the signs and symptoms of an allergic reaction, such as hives, swelling, difficulty breathing, or rash. Contact your doctor immediately if you experience any of these symptoms. It should be administered by a healthcare professional, and you should monitor yourself or your baby for any signs of problems, such as breathing problems, jaundice, or allergic reactions. Do not try to administer this medication yourself. Be aware of the signs and symptoms of an allergic reaction, bleeding, respiratory distress, apnea, and liver problems and contact your doctor immediately if you experience any of these symptoms. Be aware of the signs and symptoms of apnea, such as a temporary cessation of breathing. Contact your doctor immediately if you experience any of these symptoms.